Iconovo AB (publ) announces that the company, at the Annual General Meeting has strengthened the Board of Directors with Carl Lindgren. Carl Lindgren has extensive and broad international, commercial experience from various leading positions in the life science industry, including companies such as Karo Healthcare, Lundbeck and AstraZeneca. Carl Lindgren will soon be starting a new position as Chief Business Development Officer at EQL Pharma and he is active as a board member of the company BioMedica Norden AB.

He has previously also worked commercially with inhalation products. Carl Lindgren joined Iconovo's Board of Directors at the Annual General Meeting on May 22, 2023.